Pfizer, Inc v Paul Roberts

The parties to this proceeding were Pfizer, Inc. (the applicant) and Paul Roberts (the respondent). The dispute concerned the respondent's alleged infringement of the applicant's Australian Patent No. 700,000. The matter came before the Federal Court of Australia.

The primary legal issue before the Court was whether the respondent's product, a pharmaceutical preparation, infringed the claims of the applicant's patent. This involved a detailed examination of the patent claims and a comparison with the respondent's product to determine if it fell within the scope of the patent.

The Court applied the principles of patent infringement, including the construction of patent claims and the assessment of whether the respondent's product met the essential elements of those claims. The Court considered the evidence presented by both parties regarding the composition and function of the respondent's product in relation to the patented invention. The Court found that the respondent's product did not infringe the applicant's patent.

Consequently, the Court ordered that the application for an injunction and damages be dismissed.